Reich LA - Search Results

1

Potential therapeutic uses of rexinoids.

Leal AS, Reich LA, Moerland JA, Zhang D, Liby KT. Leal AS, et al. Among authors: reich la. Adv Pharmacol. 2021;91:141-183. doi: 10.1016/bs.apha.2021.01.004. Epub 2021 Mar 4. Adv Pharmacol. 2021. PMID: 34099107 Review.

2

Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models.

Leal AS, Zydeck K, Carapellucci S, Reich LA, Zhang D, Moerland JA, Sporn MB, Liby KT. Leal AS, et al. Among authors: reich la. NPJ Breast Cancer. 2019 Nov 1;5:39. doi: 10.1038/s41523-019-0135-5. eCollection 2019. NPJ Breast Cancer. 2019. PMID: 31700995 Free PMC article.

3

The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer.

Moerland JA, Zhang D, Reich LA, Carapellucci S, Lockwood B, Leal AS, Krieger-Burke T, Aleiwi B, Ellsworth E, Liby KT. Moerland JA, et al. Among authors: reich la. Sci Rep. 2020 Dec 17;10(1):22244. doi: 10.1038/s41598-020-79260-8. Sci Rep. 2020. PMID: 33335263 Free PMC article.

4

The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer.

Reich LA, Moerland JA, Leal AS, Zhang D, Carapellucci S, Lockwood B, Jurutka PW, Marshall PA, Wagner CE, Liby KT. Reich LA, et al. Sci Rep. 2022 Jan 7;12(1):293. doi: 10.1038/s41598-021-04415-0. Sci Rep. 2022. PMID: 34997154 Free PMC article.

5

The Novel RXR Agonist MSU-42011 Differentially Regulates Gene Expression in Mammary Tumors of MMTV-Neu Mice.

Reich LA, Leal AS, Ellsworth E, Liby KT. Reich LA, et al. Int J Mol Sci. 2023 Feb 21;24(5):4298. doi: 10.3390/ijms24054298. Int J Mol Sci. 2023. PMID: 36901727 Free PMC article.

6

Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen.

Hillman GG, Reich LA, Rothstein SE, Abernathy LM, Fountain MD, Hankerd K, Yunker CK, Rakowski JT, Quemeneur E, Slos P. Hillman GG, et al. Among authors: reich la. J Immunother Cancer. 2017 Jan 17;5:4. doi: 10.1186/s40425-016-0204-3. eCollection 2017. J Immunother Cancer. 2017. PMID: 28116088 Free PMC article.

7

Reduced intrinsic neural timescales in schizophrenia along posterior parietal and occipital areas.

Uscătescu LC, Said-Yürekli S, Kronbichler L, Stelzig-Schöler R, Pearce BG, Reich LA, Weber S, Aichhorn W, Kronbichler M. Uscătescu LC, et al. Among authors: reich la. NPJ Schizophr. 2021 Nov 22;7(1):55. doi: 10.1038/s41537-021-00184-x. NPJ Schizophr. 2021. PMID: 34811376 Free PMC article.

8

Effective Connectivity of the Hippocampus Can Differentiate Patients with Schizophrenia from Healthy Controls: A Spectral DCM Approach.

Uscătescu LC, Kronbichler L, Stelzig-Schöler R, Pearce BG, Said-Yürekli S, Reich LA, Weber S, Aichhorn W, Kronbichler M. Uscătescu LC, et al. Among authors: reich la. Brain Topogr. 2021 Nov;34(6):762-778. doi: 10.1007/s10548-021-00868-8. Epub 2021 Sep 4. Brain Topogr. 2021. PMID: 34482503 Free PMC article.

9

Preserved intention understanding during moral judgments in schizophrenia.

Kronbichler L, Stelzig-Schöler R, Lenger M, Weber S, Pearce BG, Reich LA, Aichhorn W, Kronbichler M. Kronbichler L, et al. Among authors: reich la. PLoS One. 2021 May 19;16(5):e0251180. doi: 10.1371/journal.pone.0251180. eCollection 2021. PLoS One. 2021. PMID: 34010340 Free PMC article.

10

Reduced spontaneous perspective taking in schizophrenia.

Kronbichler L, Stelzig-Schöler R, Pearce BG, Tschernegg M, Said-Yürekli S, Crone JS, Uscatescu LC, Reich LA, Weber S, Aichhorn W, Perner J, Kronbichler M. Kronbichler L, et al. Among authors: reich la. Psychiatry Res Neuroimaging. 2019 Oct 30;292:5-12. doi: 10.1016/j.pscychresns.2019.08.007. Epub 2019 Aug 16. Psychiatry Res Neuroimaging. 2019. PMID: 31472416 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page